Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

Plant extracts may help treat hormone-related hair loss.

Dutasteride may help reduce brain inflammation and improve cognition.

Personalized treatment is crucial for effectively managing benign prostatic hyperplasia (BPH).

Dermatologists should guide patients on blood donation timing due to various eligibility criteria.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

Italian guidelines recommend using trichoscopy for diagnosis and treatments like minoxidil for hair loss.

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

5-α-reductase inhibitors, intralesional steroids, and hydroxychloroquine are the most effective treatments for frontal fibrosing alopecia.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

Most care for benign prostatic hyperplasia follows guidelines, but 5-α reductase inhibitors are often used incorrectly.

Saw palmetto may improve urinary symptoms with fewer sexual side effects compared to some medications.

The letter is skeptical about the effectiveness of anti-androgen therapy for COVID-19 and calls for strong evidence from clinical trials.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

Steroid hormones are crucial for body functions and have various medical uses, but their misuse can lead to dependence.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

Current treatments for postmenopausal frontal fibrosing alopecia stop hair loss but don't regrow hair.

Dutasteride is cheaper than finasteride for treating benign prostatic hyperplasia.

New oral treatment, finasteride, effectively and safely treats common hair loss.

The body's change of testosterone into DHT is not necessary for testosterone's muscle and sexual effects.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

Tadalafil is effective for treating urinary symptoms in men with BPH.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Saw palmetto may cause erectile dysfunction and needs better safety monitoring.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

Hair loss is linked to heart disease and metabolic syndrome, and while current treatments vary in effectiveness, more research is needed for better solutions.

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.